Citi Starts MacroGenics (MGNX) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Oppenheimer Remains Bullish on Macrogenics (MGNX) Following Announced Entrance into NIAID Contract
September 18, 2015 10:54 AM UTCOppenheimer reiterated an Outperform rating and $48.00 price target on MacroGenics (NASDAQ: MGNX) following the announced entrance into a contract with the National Institute of Allergy and Infectious Diseases (NIAID) for the development of DARTs products for the treatment of HIV. NIAID will pay... More
